Literature DB >> 25029421

Increased plasma DPP4 activity is predictive of prediabetes and type 2 diabetes onset in Chinese over a four-year period: result from the China National Diabetes and Metabolic Disorders Study.

Tianpeng Zheng1, Yun Gao, Attit Baskota, Tao Chen, Xingwu Ran, Haoming Tian.   

Abstract

CONTEXT: The significance of associations between prediabetes, type 2 diabetes, and dipeptidyl peptidase-4 (DPP4) activity in a Chinese population is not clear.
OBJECTIVE: The objective of the study was to determine whether DPP4 activity and active glucagon-like peptide-1 (GLP-1) were predictive of the onset of prediabetes and type 2 diabetes. DESIGN, SETTING, AND PATIENTS: This was a 4-year follow-up study conducted in Sichuan, China. A total of 474 Chinese women and men aged 18-70 years were studied. MAIN OUTCOME MEASURES: All subjects were divided into 3 groups (normal glucose tolerance, prediabetes, and type 2 diabetes) on the basis of their glucose metabolism status after 4 years. The DPP4 activity, active GLP-1, and glucagon were measured at baseline and 4 years later.
RESULTS: The baseline DPP4 activity was significantly higher in subjects who had progressed to prediabetes or type 2 diabetes compared with subjects who remained normoglycemic (P < .01). In a multiple linear regression analysis, baseline DPP4 activity and active GLP-1 were independent predictors of an increase in insulin resistance over a 4-year period (P < .05). Cox proportional hazards models revealed that DPP4 activity independently predicted the risk of developing prediabetes [relative risk 2.77 (95% confidence interval 1.38-5.55), P < .01] and type 2 diabetes [5.10 (95% confidence interval 1.48-17.61), P < .05] after adjustment for confounding risk factors.
CONCLUSIONS: DPP4 activity is an important predictor of the onset of insulin resistance, prediabetes, and type 2 diabetes in apparently healthy Chinese individuals. This finding may have important implications for understanding the etiology of diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25029421     DOI: 10.1210/jc.2014-1480

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

Review 1.  Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs.

Authors:  Carolin Thomas; Lia Wurzer; Ernst Malle; Michael Ristow; Corina T Madreiter-Sokolowski
Journal:  Front Aging       Date:  2022-06-14

Review 2.  DPP4 Activity, Hyperinsulinemia, and Atherosclerosis.

Authors:  Kaitlin M Love; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

Review 3.  Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?

Authors:  Wellington Santana da Silva Júnior; Amélio Fernando de Godoy-Matos; Luiz Guilherme Kraemer-Aguiar
Journal:  Biomed Res Int       Date:  2015-06-04       Impact factor: 3.411

Review 4.  Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?

Authors:  Matthias Ploug Larsen; Signe Sørensen Torekov
Journal:  J Diabetes Res       Date:  2017-09-10       Impact factor: 4.011

5.  Strong Association between Plasma Dipeptidyl Peptidase-4 Activity and Impaired Cognitive Function in Elderly Population with Normal Glucose Tolerance.

Authors:  Bo Chen; Tianpeng Zheng; Linyuan Qin; Xueping Hu; Xiaoxi Zhang; Yihong Liu; Hongbo Liu; Shenghua Qin; Gang Li; Qinghua Li
Journal:  Front Aging Neurosci       Date:  2017-07-26       Impact factor: 5.750

6.  Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage.

Authors:  Mickaël J Ploquin; Armanda Casrouge; Yoann Madec; Nicolas Noël; Beatrice Jacquelin; Nicolas Huot; Darragh Duffy; Simon P Jochems; Luca Micci; Camille Lécuroux; Faroudy Boufassa; Thijs Booiman; Thalia Garcia-Tellez; Mathilde Ghislain; Roger Le Grand; Olivier Lambotte; Neeltje Kootstra; Laurence Meyer; Cecile Goujard; Mirko Paiardini; Matthew L Albert; Michaela Müller-Trutwin
Journal:  J Int AIDS Soc       Date:  2018-07       Impact factor: 5.396

7.  Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients.

Authors:  Jit Sarkar; Titli Nargis; Om Tantia; Sujoy Ghosh; Partha Chakrabarti
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-25       Impact factor: 5.555

8.  The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort.

Authors:  Gilberto Vargas-Alarcón; María Del Carmen González-Salazar; Christian Vázquez-Vázquez; Adrián Hernández-Díaz Couder; Fausto Sánchez-Muñoz; Juan Reyes-Barrera; Sergio A Criales-Vera; Marco Sánchez-Guerra; Citlalli Osorio-Yáñez; Rosalinda Posadas-Sánchez
Journal:  Front Genet       Date:  2021-06-11       Impact factor: 4.599

9.  Vitamin D and Incidence of Prediabetes or Type 2 Diabetes: A Four-Year Follow-Up Community-Based Study.

Authors:  Yun Gao; Tianpeng Zheng; Xingwu Ran; Yan Ren; Tao Chen; Li Zhong; Donge Yan; Fangfang Yan; Qianlin Wu; Haoming Tian
Journal:  Dis Markers       Date:  2018-03-18       Impact factor: 3.434

10.  Association of Serum Angiopoietin-Like Protein 8 With Albuminuria in Type 2 Diabetic Patients: Results From the GDMD Study in China.

Authors:  Liuxue Yang; Jianfei Song; Xiaoxi Zhang; Liuping Xiao; Xueping Hu; Haidong Pan; Linyuan Qin; Hongbo Liu; Bo Ge; Tianpeng Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.